Safety of Typhim Vi Vaccine in a Postmarketing Observational Study

This publication has 10 references indexed in Scilit:

• Health care of the long-term traveller
  Travel Medicine and Infectious Disease, 2005
• A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial
  BMC Public Health, 2005
• Typhoid Fever in Travelers: Who Should Be Targeted for Prevention?
  Clinical Infectious Diseases, 2004
• Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002
  Clinical Infectious Diseases, 2004
• Preparing the traveller
  The Lancet, 2003
• Typhoid Fever
  New England Journal of Medicine, 2002
• Experience With Salmonella typhi Vi Capsular Polysaccharide Vaccine
  European Journal of Clinical Microbiology & Infectious Diseases, 1999
• Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines
  Vaccine, 1994
• PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER
  The Lancet, 1987
• Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella Typhi
  New England Journal of Medicine, 1987